ADHD Patients Successfully Treated with Cannabis

High Times:Normal Blog: BY PAUL ARMENTANO • OCT 26, 2015

ADHD Adults Resistant to Conventional Therapies Respond Favorably to “Pot”

The use of herbal cannabis was found to improve concentration, sleep and impulsivity in ADHD adults proven resistant to alternative treatments, according to clinical trial data.

According to Dr. Harold Levinson, these clinical data are consistent with sporadic anecdotal findings reported by some of his ADHD patients, albeit others have been negatively affected by cannabis.

ADHD and related disorders such as dyslexia were found by Levinson to be complex multi determined and compensated disorders. As a result, it is possible that “pot” may alleviate superimposed anxiety or depressive mechanisms in some while destabilizing causative determinants in others. Needless to say, the same is true for conventional meds, thus explaining both the typical and atypical responses noted when holistically treating these disorders.

Indeed, by analyzing the many and diverse favorable responses of ADHD and dyslexic patients to treatments, Levinson was able to obtain the best multidimensional perspective of these frequently overlapping disorders to date. Clearly, more detailed analyses of similar responses to cannabis and other substances will add to these perspectives, perhaps leading to other helpful non-traditional therapies.

About Dr. Harold Levinson
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. For more information, call 1(800)334-7323 or
visit: http://www.dyslexiaonline.com
Source: http://www.hightimes.com/read/norml-blog-adhd-patients-successfully-treated-cannabis?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+HIGHTIMESMagazine+(HIGH+TIMES+Magazine)

Image courtesy of Paul/FreeDigitalPhotos.net

Comments are closed.